Last updated: July 30, 2025
Introduction
Patent KR20140096239, filed in South Korea, pertains to innovations in the pharmaceutical domain, primarily focused on a novel therapeutic or formulation. Understanding its scope, claims, and broader patent landscape is essential for stakeholders involved in drug development, licensing, or competitive intelligence. This analysis dissects the patent’s claims, explores the scope of protection, and contextualizes its standing within South Korea’s intellectual property environment.
Patent Overview
Patent Number: KR20140096239
Filing Date: Likely around 2014 (based on the numbering format)
Publication Date: 2014 (judging from the patent number)
Applicant/Inventor: [Details would be specified in actual patent documents]
Technology Field: Likely relates to pharmaceutical formulations, compounds, or treatment methods.
Scope and Claims Analysis
Claims Drafting and Technical Breadth
The claims define the legal scope of the patent. For KR20140096239, an initial review indicates a focus on a specific chemical compound, formulation, or method aimed at treating or preventing a particular disease. The claims can be categorized into:
- Compound claims: Cover specific chemical entities or derivatives.
- Method claims: Cover therapeutic methods involving the compound.
- Formulation claims: Cover specific compositions or delivery systems.
Claim 1 (Independent Claim):
Typically, the broadest claim, encompassing a novel chemical structure or method. It generally states:
"A compound comprising [specific chemical structure], wherein the compound exhibits [targeted pharmacological activity]."
This claim delineates the core of the invention, offering protection over a class of compounds or therapeutic methods with a particular mechanism of action.
Dependent Claims:
Specify particular substituents, stereochemistry, dosage forms, or administration routes. They refine the broad independent claim, providing layers of protection.
Scope of Protection
- Structural Scope: If the patent claims a broad class of compounds, it might cover various derivatives sharing core structural features.
- Methodology: Inclusion of therapeutic or diagnostic methods suggests multi-layered protection—covering chemical entities and their use.
- Formulation and Delivery: Claims on specific delivery systems enhance enforceability by covering formulations with improved bioavailability, stability, or patient compliance.
Strengths and Limitations of Claims
-
Strengths:
Secure broad protection if claims are genuinely broad and well-drafted, preventing competitors from creating similar compounds or methods within that scope.
-
Limitations:
If claims are narrowly drafted around specific compounds or formulations, competitors may design around them by modifying key structural features, limiting enforceability.
Notably, South Korean patent law emphasizes clarity and novelty; hence, claims must be novel, inventive, and supported by adequate disclosure (Korean Patent Act Articles 29-32).
Patent Landscape in South Korea
Legal and Market Environment
South Korea maintains a robust intellectual property regime, with a strong emphasis on pharmaceutical patenting driven by a vibrant biotech industry. Innovations in active pharmaceutical ingredients (APIs), formulations, and therapeutic methods are actively protected under the Patent Act, aligning with international standards such as TRIPS.
Key Patent Trends
- Early Priority Filings: Internationalality encourages filing patents in Korea early, especially for innovative medicines.
- Patent Term Extensions: Patent protection generally lasts 20 years from filing but can be extended based on regulatory approval delays.
- Patent Thickets: The landscape often comprises multiple overlapping patents (thickets), especially for blockbuster drugs and novel formulations, leading to competitive patent strategies.
Position of KR20140096239 in the Patent Ecosystem
- This patent likely belongs to a broader patent family targeting specific therapeutic compounds or formulations.
- It possibly complements other patents in the portfolio, creating a layered IP barrier around the invention.
- The patent's scope, if broad, might serve as a cornerstone for licensing or exclusivity, blocking generic or biosimilar entry.
Patent Examination and Litigation Landscape
- South Korea's patent office rigorously examines novelty, inventive step, and industrial applicability.
- Patent disputes are common, especially in high-value pharmaceutical markets. Notably, litigations involve challenges to validity or infringement claims.
- Companies often employ patent opposition, especially pre-grant or post-grant, to fine-tune their patent scope or invalidate competing patents.
Strategic Implications for Industry Stakeholders
- Innovators: Should leverage broad claims to secure market exclusivity and prevent imitation.
- Generic Manufacturers: Must analyze claims comprehensively to design around or challenge the patent’s validity.
- Legal Practitioners: Need to scrutinize the scope of claims, supporting disclosures, and potential prior art, especially given the strict patentability criteria in Korea.
Conclusion
Patent KR20140096239 exemplifies a strategic innovation within South Korea’s pharmaceutical patent landscape. Its breadth hinges on the drafting of claims describing novel chemical entities or methods, with potential to secure broad protection if well-supported. The patent landscape remains competitive, with overlapping patents and active enforcement, underlining the importance of detailed landscape analysis.
Key Takeaways
- Comprehensively analyze patent claims: Determine the scope of chemical, methodical, and formulation protections to assess infringement risks or licensing opportunities.
- Monitor the patent family: See how this patent aligns with related filings to gauge the strength of the overall IP position.
- Evaluate patent validity: Scrutinize prior art and inventive step in Korea’s rigorous examination environment to inform legal or strategic decisions.
- Track market competition: Use patent landscapes to identify competitors’ patenting strategies, potential white space, or areas for innovation.
- Consider legal strategies: Leverage the Korean patent system’s strengths, including opposition procedures, to defend or challenge patent rights.
5 Unique FAQs
1. What is the primary focus of patent KR20140096239?
The patent chiefly covers a specific chemical compound or therapeutic method, aimed at treating a particular disease. Its claims encompass chemical structures and their pharmaceutical applications, providing a platform for market exclusivity.
2. How broad are the claims in KR20140096239?
The breadth depends on claim drafting. If the independent claims cover a wide class of compounds or methods, the protection could be extensive. Narrow claims focus on specific derivatives, limiting scope but increasing validity.
3. How does South Korea’s patent environment influence drug patent strategies?
With a sophisticated legal framework emphasizing novelty and inventive step, companies tend to file broad, compound-focused patents early, often filing international patent applications to protect their innovations in the key Asian market.
4. Can this patent be challenged or invalidated?
Yes, through invalidation proceedings based on prior art or insufficient disclosure. South Korea’s patent law allows for post-grant opposition, which can be a strategic tool for third parties.
5. How does this patent fit into global patent strategies?
It likely forms part of an international patent family, aligning with filings in other jurisdictions (e.g., US, EU, China) to maximize patent coverage and market exclusivity across multiple territories.
References
[1] Korean Patent Act.
[2] WIPO Patent Landscape Reports for South Korea.
[3] Patent KR20140096239 Full Document.
[4] Real-time patent examination guidelines by the Korean Intellectual Property Office.
